Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00090571 · ClinicalTrials.gov registry record

Juvenile Rheumatoid Arthritis Research Registry

A clinical trial of Juvenile Rheumatoid Arthritis, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

Completed
Registry status
200
Enrollment target
1
Study location

NCT00090571 is a study of Juvenile Rheumatoid Arthritis that has completed, run by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The registered enrollment target is 200 participants, above the 70-participant average among 3 other Juvenile Rheumatoid Arthritis trials with a reported enrollment target (186% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00090571, a study of Juvenile Rheumatoid Arthritis, has completed, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

COMPLETED
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Juvenile rheumatoid arthritis (JRA) is the most common chronic inflammatory disease in children, and may be related to genetics. Having two siblings who both have JRA in one family is rare. The purpose of this registry is to collect patient information and blood samples from qualifying JRA siblings and their families. The goal of the registry is to further understanding of JRA as related to genetics.

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 1994-10
Est. Completion 2009-09

What the Registry Record Tells You About NCT00090571

The ClinicalTrials.gov registry entry for NCT00090571 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 70-participant average among 3 other Juvenile Rheumatoid Arthritis trials with a reported enrollment target (186% higher). The listed sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Juvenile Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.

NCT00090571 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00090571 about?

NCT00090571 is a clinical study titled "Juvenile Rheumatoid Arthritis Research Registry". Juvenile rheumatoid arthritis (JRA) is the most common chronic inflammatory disease in children, and may be related to genetics. Having two siblings who both have JRA in one family is rare. The purpose of this registry is to collect patient information and blood samples from qualifying JRA siblings ...

What is the current status of trial NCT00090571?

This trial is currently completed. The enrollment target is 200 participants. The study started on 1994-10. Estimated completion is 2009-09.

What conditions does trial NCT00090571 study?

This clinical trial studies the following conditions: Juvenile Rheumatoid Arthritis.

Who is sponsoring clinical trial NCT00090571?

This trial is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00090571 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Juvenile Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.